ARCHIVES

Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 9 | September 26, 2003

Download PDF Visit The Full Archive

Related Articles

Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials.

December 2, 2005

Administration Seeks Increase In FDA Budget.

June 13, 2008

“5 A Day” Review Underway to Check Program’s Health at NCI.

March 31, 2000

Not All Women Benefitting From Less Invasive Staging

April 25, 2008

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

September 11, 1998

NCCS Networker Volume 5 Issue 4, Fall 1991

September 13, 1991